Welcome to Mayo Clinic's Covid-19 (SARS-CoV-2) Nucleocapsid Total Antibody (COVTA) screening. In the ever-evolving landscape of the Covid-19 pandemic, understanding your immune response is essential. This test is designed to detect antibodies against the virus's nucleocapsid protein, offering insights into your Covid-19 history, immunity status, and vaccination effectiveness.
Click here to view sample COVTA Testing Report:
Covid-19 (SARS-CoV-2), Nucleocapsid, Total Antibody (COVTA)